Understanding fibromyalgia: A comprehensive review of the literature

IF 1 Q4 RHEUMATOLOGY
Nora Y. Elsaid
{"title":"Understanding fibromyalgia: A comprehensive review of the literature","authors":"Nora Y. Elsaid","doi":"10.1016/j.ejr.2025.02.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Fibromyalgia (FM) is a complex and debilitating chronic pain condition affecting millions of people worldwide. It is characterized by widespread musculoskeletal pain often accompanied by fatigue, cognitive dysfunction, sleep disturbance, psychiatric issues, and various somatic symptoms. It is more prevalent in women between 30 and 60 years.</div></div><div><h3>Aim of the work</h3><div>To provide a comprehensive overview on FM, covering its pathophysiology, diagnostic criteria, the role of artificial intelligence (AI), and available treatment options.</div></div><div><h3>Review</h3><div>The <em>pathophysiology</em> of FM remains poorly understood and may involve a combination of genetic, environmental, and psychological factors that lead to abnormal pain processing in the central nervous system. <em>Diagnosis</em> is primarily clinical after exclusion of other conditions. The overlap between FM, chronic pain syndromes and post-coronavirus disease 2019 (COVID-19) syndrome or “long COVID-19” is still debatable. Till now there have been no definitive laboratory tests or imaging studies to diagnose FM. <em>Management</em>, often a multidisciplinary approach, includes pharmacological treatments, physical therapy, cognitive-behavioral therapy, and lifestyle modifications such as exercise and stress management techniques. The adoption of AI in its diagnosis and management is a new area of interest in FM. Ongoing research is focused on elucidating the pathophysiological mechanisms underlying FM and developing innovative therapeutic strategies.</div></div><div><h3>Conclusion</h3><div>This review highlights the importance of a multidimensional approach to FM management, including pharmacological interventions, non-pharmacological therapies, and psychological support. Furthermore, it urges the need for further research to unravel the underlying mechanisms contributing to FM, to improve the diagnosis and management of this challenging condition.</div></div>","PeriodicalId":46152,"journal":{"name":"Egyptian Rheumatologist","volume":"47 2","pages":"Pages 90-97"},"PeriodicalIF":1.0000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Rheumatologist","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1110116425000067","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Fibromyalgia (FM) is a complex and debilitating chronic pain condition affecting millions of people worldwide. It is characterized by widespread musculoskeletal pain often accompanied by fatigue, cognitive dysfunction, sleep disturbance, psychiatric issues, and various somatic symptoms. It is more prevalent in women between 30 and 60 years.

Aim of the work

To provide a comprehensive overview on FM, covering its pathophysiology, diagnostic criteria, the role of artificial intelligence (AI), and available treatment options.

Review

The pathophysiology of FM remains poorly understood and may involve a combination of genetic, environmental, and psychological factors that lead to abnormal pain processing in the central nervous system. Diagnosis is primarily clinical after exclusion of other conditions. The overlap between FM, chronic pain syndromes and post-coronavirus disease 2019 (COVID-19) syndrome or “long COVID-19” is still debatable. Till now there have been no definitive laboratory tests or imaging studies to diagnose FM. Management, often a multidisciplinary approach, includes pharmacological treatments, physical therapy, cognitive-behavioral therapy, and lifestyle modifications such as exercise and stress management techniques. The adoption of AI in its diagnosis and management is a new area of interest in FM. Ongoing research is focused on elucidating the pathophysiological mechanisms underlying FM and developing innovative therapeutic strategies.

Conclusion

This review highlights the importance of a multidimensional approach to FM management, including pharmacological interventions, non-pharmacological therapies, and psychological support. Furthermore, it urges the need for further research to unravel the underlying mechanisms contributing to FM, to improve the diagnosis and management of this challenging condition.
理解纤维肌痛:文献综述
纤维肌痛(FM)是一种复杂的、使人衰弱的慢性疼痛状况,影响着全世界数百万人。其特征是广泛的肌肉骨骼疼痛,常伴有疲劳、认知功能障碍、睡眠障碍、精神问题和各种躯体症状。它在30至60岁的女性中更为普遍。提供FM的全面概述,包括其病理生理学,诊断标准,人工智能(AI)的作用,以及可用的治疗方案。FM的病理生理学仍然知之甚少,可能涉及遗传、环境和心理因素的组合,导致中枢神经系统异常的疼痛处理。排除其他情况后,诊断主要是临床诊断。FM、慢性疼痛综合征和2019冠状病毒后疾病(COVID-19)综合征或“长型COVID-19”之间的重叠仍然存在争议。到目前为止,还没有明确的实验室测试或影像学研究来诊断FM。管理,通常是一个多学科的方法,包括药物治疗,物理治疗,认知行为治疗,和生活方式的改变,如运动和压力管理技术。人工智能在其诊断和管理中的应用是FM的一个新领域。目前的研究主要集中在阐明FM的病理生理机制和开发创新的治疗策略。结论本综述强调了从多方面进行FM治疗的重要性,包括药物干预、非药物治疗和心理支持。此外,它敦促需要进一步的研究来揭示导致FM的潜在机制,以改善这一具有挑战性的疾病的诊断和管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Egyptian Rheumatologist
Egyptian Rheumatologist RHEUMATOLOGY-
CiteScore
2.00
自引率
22.20%
发文量
77
审稿时长
39 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信